Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W. Asinger

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American College of Cardiology|June 13, 2015
Atrial Fibrillation and Renal Function: How High Is the Price of Anticoagulation?Richard W Asinger, Gautam R Shroff
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2015
Atrial Fibrillation and Stroke: It's About Point of ViewDavid C Anderson, Richard W Asinger
JACC. Cardiovascular Imaging|July 16, 2011
Detecting LV thrombi: "T'ain't what you do (it's the way that you do it)"Richard W Asinger, Charles A Herzog
The New England Journal of Medicine|December 4, 2003
ST-segment elevation in conditions other than acute myocardial infarctionKyuhyun Wang, Richard W Asinger, Henry J L Marriott
Journal of Electrocardiology|October 31, 2006
Bigeminal rhythms, common and uncommon mechanismsKyuhyun Wang, Richard W Asinger, Henry J L Marriott
Circulation|November 2, 2016
Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"Richard W Asinger, Gautam R Shroff, Charles A Herzog
Current Treatment Options in Cardiovascular Medicine|November 7, 2001
Left Ventricular ThrombusPeter J. Stokman, Charn S. Nandra, Richard W. Asinger
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseRobert G Hart, Lesly A Pearce, Richard W Asinger, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|August 18, 2011
Right ventricular diverticulumSrinivasan Sattiraju, Woubeshet Ayenew, Gopal Punjabi, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2022
Use of SAMe-TT<sub>2</sub>R<sub>2</sub> in a racially diverse anticoagulation clinic: prediction of optimal anticoagulationKunkun Wang, Yun Lu, Mengistu A Simegn, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American College of Cardiology|June 13, 2015
Atrial Fibrillation and Renal Function: How High Is the Price of Anticoagulation?Richard W Asinger, Gautam R Shroff
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2015
Atrial Fibrillation and Stroke: It's About Point of ViewDavid C Anderson, Richard W Asinger
JACC. Cardiovascular Imaging|July 16, 2011
Detecting LV thrombi: "T'ain't what you do (it's the way that you do it)"Richard W Asinger, Charles A Herzog
The New England Journal of Medicine|December 4, 2003
ST-segment elevation in conditions other than acute myocardial infarctionKyuhyun Wang, Richard W Asinger, Henry J L Marriott
Journal of Electrocardiology|October 31, 2006
Bigeminal rhythms, common and uncommon mechanismsKyuhyun Wang, Richard W Asinger, Henry J L Marriott
Circulation|November 2, 2016
Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"Richard W Asinger, Gautam R Shroff, Charles A Herzog
Current Treatment Options in Cardiovascular Medicine|November 7, 2001
Left Ventricular ThrombusPeter J. Stokman, Charn S. Nandra, Richard W. Asinger
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseRobert G Hart, Lesly A Pearce, Richard W Asinger, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|August 18, 2011
Right ventricular diverticulumSrinivasan Sattiraju, Woubeshet Ayenew, Gopal Punjabi, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2022
Use of SAMe-TT<sub>2</sub>R<sub>2</sub> in a racially diverse anticoagulation clinic: prediction of optimal anticoagulationKunkun Wang, Yun Lu, Mengistu A Simegn, et al.
Pageof 2